Diana Brainard, CEO, Director at Kalaris Therapeutics, holds 723.36K shares in Kalaris Therapeutics (Ticker: KLRS), holds 28.56K shares in Nektar Therapeutics (Ticker: NKTR). Most recently, Diana Brainard Sold ― shares of Kalaris Therapeutics on Nov 20, 2024 for an estimated value of $4.70K.
What is the percentage of profitable transactions made by Diana Brainard?
The percentage of profitable transactions made by Diana Brainard is 93%.
What is the average return per transaction made by Diana Brainard?
The average return per transaction made by Diana Brainard is 61.10%.
What stocks does Diana Brainard hold?
Diana Brainard holds: KLRS, NKTR stocks.
What was Diana Brainard’s latest transaction?
Diana Brainard latest transaction was an Informative Sell of $4.70K.
What was Diana Brainard's most profitable transaction?
Diana Brainard’s most profitable transaction was an Informative Sell of KLRS stock on August 22, 2024. The return on the trade was 85.70%.
What is Diana Brainard's role in Kalaris Therapeutics?
Diana Brainard's role in Kalaris Therapeutics is CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.